Are Labs Ready for HPV Self-sampling?

How AI-assisted digital cytology could ease the burden on labs from increased cervical screening uptake

By
Helen Bristow
October 7, 2026
5 min

The Pathologist

Overview

The article examines how HPV self-sampling may affect cervical screening laboratory workflows and how AI-assisted digital cytology could support slide review. A BMJ Open model-based evaluation estimated reductions of around 69% in slide-review time, with estimated productivity gains of 76% in primary screening and 64% in consultant review; specialists retain responsibility for decisions.

Background

NHS England has rolled out HPV self-sampling to increase participation in cervical screening, including among people who have not attended or whose attendance has lapsed. The article notes that changes in screening entry may alter laboratory sample volumes and the types of samples requiring downstream assessment. It also describes clinician-collected cervical samples as the gold standard for sample quality and for cytology when further assessment is needed. Laboratory adoption of digital cytology involves infrastructure, secure image handling, system integration, training, validation, quality assurance, and governance.

Data Highlights

Measure	Reported estimate	Source context
Reduction in slide-review time	Around 69%	AI-assisted digital cytology model using the current NHS cervical screening pathway
Productivity gain in primary screening	76%	BMJ Open model-based evaluation, as reported in the article
Productivity gain in consultant review	64%	BMJ Open model-based evaluation, as reported in the article
Self-collected versus clinician-administered HPV samples	193 women; study described as finding equivalent detection of high-risk HPV	Related study summary; participants were screened between 2020 and 2022
Provider attitudes toward offering self-collection	More than 50% of surveyed providers might offer testing if FDA-approved	Related study summary

Key Findings

The article reports that NHS England introduced HPV self-sampling to increase cervical screening uptake and says laboratories should plan for its effects across the screening pathway.
Alison Cropper said self-sampling could change both cytology volumes and the types of samples laboratories receive.
Amandeep Chohan described clinician-taken samples as the gold standard and said digital cytology and AI-assisted review can help identify relevant cells for expert review.
The BMJ Open evaluation estimated around 69% less slide-review time, with productivity gains estimated at 76% in primary screening and 64% in consultant review.
The experts emphasized that specialists retain decision-making responsibility; AI-assisted review is intended to direct attention to cells requiring closer assessment.
The experts identified digital infrastructure, secure image storage and sharing, integration with existing systems, training, validation, quality assurance, and governance as requirements for implementation, particularly when cases are shared across organizations.

Clinical Implications

The experts describe AI-assisted digital cytology as a potential way to allocate specialist time to interpretation, complex cases, quality assurance, and training, while enabling cases to be redistributed between laboratories. They state that implementation requires appropriate infrastructure and governance, and that specialist review and decision-making remain central.

Conclusion

The article presents HPV self-sampling and AI-assisted digital cytology as developments that laboratories need to consider together. The reported time and productivity estimates are model-based, and the experts identify workflow, quality, and governance requirements for safe implementation.